Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 8678386)

Published in Ann Intern Med on July 15, 1996

Authors

F M Rahhal1, J F Arevalo, E Chavez de la Paz, D Munguia, S P Azen, W R Freeman

Author Affiliations

1: University of California School of Medicine, San Diego, USA.

Articles by these authors

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA (1987) 5.82

The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med (1998) 4.92

Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol (1997) 3.99

Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03

Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94

Ethnicity and attitudes towards life sustaining technology. Soc Sci Med (1999) 2.93

Topical anesthesia in posterior vitrectomy. Retina (2000) 2.85

Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology (1996) 2.70

Reliability of goniometric measurements. Phys Ther (1978) 2.52

Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology (1997) 2.49

Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47

Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol (1997) 2.42

Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol (1993) 2.38

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA (1990) 2.36

Scoliosis: A prospective epidemiological study. J Bone Joint Surg Am (1975) 2.22

Normal range of motion of joints in male subjects. J Bone Joint Surg Am (1979) 2.14

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis (1997) 2.14

The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol (1994) 2.05

Visual outcome in acute retinal necrosis. Retina (1993) 1.99

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89

Retina and vitreous pathology after laser-assisted in situ keratomileusis: is there a cause-effect relationship? Ophthalmology (2001) 1.84

Topical anesthesia for phacoemulsification, intraocular lens implantation, and posterior vitrectomy. J Cataract Refract Surg (1999) 1.82

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82

Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82

Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol (1998) 1.73

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis (1998) 1.71

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med (1990) 1.71

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol (1984) 1.70

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Ophthalmology (1996) 1.66

Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology (1987) 1.62

Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol (1987) 1.58

Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation (1991) 1.56

Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol (1995) 1.55

Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina (2001) 1.53

Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population. Ophthalmology (1996) 1.52

Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest (1995) 1.47

Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44

Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44

Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology (1993) 1.43

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43

Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion. Eur J Ophthalmol (2001) 1.39

Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis (1999) 1.39

Hypothesis testing of time-dependent recurrent events. Stat Med (1987) 1.38

Evaluation of an expert system on lymph node pathology. Hum Pathol (1997) 1.38

Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38

Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol (1995) 1.35

Evidence for genetic control of nondisjunction in man. Am J Hum Genet (1980) 1.34

Demonstration of herpes group virus in acute retinal necrosis syndrome. Am J Ophthalmol (1986) 1.33

Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol (2000) 1.33

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes (2000) 1.31

Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol (1980) 1.30

Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29

Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol (1997) 1.28

Embedding health-promoting changes into the daily lives of independent-living older adults: long-term follow-up of occupational therapy intervention. J Gerontol B Psychol Sci Soc Sci (2001) 1.26

Confocal laser tomographic analysis of the retina in eyes with macular hole formation and other focal macular diseases. Am J Ophthalmol (1989) 1.25

Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol (1987) 1.22

Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol (1997) 1.22

Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br J Ophthalmol (2008) 1.22

Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology (1995) 1.22

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1990) 1.21

Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol (1989) 1.17

Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol (1996) 1.16

Multifactorial probit analysis of mortality in burned patients. Ann Surg (1979) 1.16

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14

Mechanism of NaCl reabsorption by hamster thin ascending limbs of Henle's loop. Am J Physiol (1975) 1.14

Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol (1998) 1.13

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA (1995) 1.13

Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.11

Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome. West J Med (1993) 1.10

The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. Control Clin Trials (1987) 1.09

Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol (1999) 1.08

Evaluation and comparison of sources of variability in the measurement of corneal thickness with ultrasonic and optical pachymeters. Ophthalmic Surg (1983) 1.08

Wave-front generation of Zernike polynomial modes with a micromachined membrane deformable mirror. Appl Opt (1999) 1.07

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol (1983) 1.07

The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Arch Ophthalmol (1995) 1.06

The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology (1998) 1.05

Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the Transfusion Safety Study. The Transfusion Safety Study Group. Clin Immunol Immunopathol (1990) 1.05

Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group. Am J Ophthalmol (1993) 1.05

Axial intensity distribution analysis of the human retina with a confocal scanning laser tomograph. Exp Eye Res (1994) 1.03

Oral fluorescein angiography with the confocal scanning laser ophthalmoscope. Ophthalmology (1999) 1.03

Los Angeles air pollution and asthma in children. Ann Allergy (1981) 1.03

Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol (1996) 1.01

Silicone oil in the repair of pediatric complex retinal detachments: a prospective, observational, multicenter study. Ophthalmology (1999) 1.01

Automated scanning laser ophthalmoscope image montages of retinal diseases. Ophthalmology (1999) 1.01

A graphical analysis of the interrelationships among waterborne asbestos, digestive system cancer and population density. Environ Health Perspect (1983) 1.01

Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification. Ophthalmology (1992) 1.01